Cirrosi epatica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cirrosi epatica" in Italian language version.

refsWebsite

Global rank Italian rank

124nih.gov

4^th place

9^th place

78doi.org

2^nd place

7^th place

22oadoi.org

799^th place

22^nd place

12archive.org

6^th place

8^th place

6web.archive.org

1^st place

5journal-of-hepatology.eu

low place

4wjgnet.com

low place

3rsna.org

9,820^th place

low place

3bmj.com

1,226^th place

928^th place

2google.it

215^th place

4^th place

2who.int

195^th place

342^nd place

2nature.com

234^th place

226^th place

2wiley.com

222^nd place

243^rd place

2uw.edu

low place

1treccani.it

182^nd place

6^th place

1books.google.com

3^rd place

14^th place

1scielo.br

1,606^th place

2,745^th place

1cdc.gov

218^th place

774^th place

1istat.it

202^nd place

18^th place

1thelancet.com

2,393^rd place

2,216^th place

1oecd-ilibrary.org

6,201^st place

7,539^th place

1iss.it

low place

1,085^th place

1salute.gov.it

low place

615^th place

1easl.eu

low place

1atsjournals.org

low place

1mdpi.com

2,912^th place

1,439^th place

1egyptianjournal.xyz

low place

1mayoclinic.org

1,610^th place

3,832^nd place

1thieme-connect.com

low place

1f1000research.com

low place

1oup.com

485^th place

613^th place

1worldcat.org

5^th place

26^th place

1unibo.it

4,963^rd place

325^th place

1quintessenz.de

low place

1aafp.org

1,916^th place

4,345^th place

1jamanetwork.com

2,650^th place

2,089^th place

1ovid.com

low place

6,061^st place

1gutnliver.org

low place

1ijnm.in

low place

1nhs.uk

1,989^th place

3,151^st place

1jkms.org

low place

1cfp.ca

low place

1emedicinehealth.com

8,799^th place

low place

aafp.org

(EN) Johnston DE, Special considerations in interpreting liver function tests, in Am Fam Physician, vol. 59, n. 8, aprile 1999, pp. 2223-30, PMID 10221307.

archive.org

(EN) Sørensen HT, Thulstrup AM, Mellemkjar L, et al., Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark, in Journal of Clinical Epidemiology, vol. 56, n. 1, 2003, pp. 88-93, DOI:10.1016/S0895-4356(02)00531-0, PMID 12589875.
(EN) K. Shetty, Chronic viral hepatitis, Humana Press, 2009, p. 216, ISBN 978-1-934115-81-7.
(EN) ed. Dan L. Longo, Harrison's principles of internal medicine., 18th, New York, McGraw-Hill, 2012, pp. Chapter 308. Cirrhosis and Its Complications, ISBN 978-0-07-174889-6.
(EN) ed. Dan L. Longo, Harrison's principles of internal medicine., 18th, New York, McGraw-Hill, 2011, p. Liver Transplantation, ISBN 978-0-07-174889-6.
(EN) David Brenner, Richard A. Rippe, Pathogenesis of Hepatic Fibrosis, in Tadataka Yamada (a cura di), Textbook of Gastroenterology, vol. 2, 4th, Lippincott Williams & Wilkins, 2003, ISBN 978-0-7817-2861-4.
(EN) Ginés P, Arroyo V, Quintero E, Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study, in Gastroenterology, vol. 93, n. 2, 1987, pp. 234-41, PMID 3297907.
(EN) Manning DS, Afdhal NH, Diagnosis and quantitation of fibrosis, in Gastroenterology, vol. 134, n. 6, maggio 2008, pp. 1670-81, DOI:10.1053/j.gastro.2008.03.001, PMID 18471546.
(EN) Foucher J, Chanteloup E, Vergniol J, et al., Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, in Gut, vol. 55, n. 3, 2006, pp. 403-8, DOI:10.1136/gut.2005.069153, PMC 1856085, PMID 16020491.
(EN) Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Transection of the oesophagus for bleeding oesophageal varices, in Br J Surg, vol. 60, n. 8, 1973, pp. 646-9, DOI:10.1002/bjs.1800600817, PMID 4541913.
(EN) M. Malinchoc, PS. Kamath; FD. Gordon; CJ. Peine; J. Rank; PC. ter Borg, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts., in Hepatology, vol. 31, n. 4, aprile 2000, pp. 864-71, DOI:10.1053/he.2000.5852, PMID 10733541.
(EN) PS. Kamath, WR. Kim, The model for end-stage liver disease (MELD)., in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) RN. Pugh, IM. Murray-Lyon; JL. Dawson; MC. Pietroni; R. Williams, Transection of the oesophagus for bleeding oesophageal varices., in Br J Surg, vol. 60, n. 8, agosto 1973, pp. 646-9, PMID 4541913.

atsjournals.org

(EN) M.F. Dawwas, Prevalence and Risk Factors for Liver Involvement in Individuals with PiZZ-related Lung Disease, in Am. J. Respir. Crit. Care Med., vol. 187, 2013, PMID 23262512.

bmj.com

gut.bmj.com

(EN) A Grant, Neuberger J, Guidelines on the use of liver biopsy in clinical practice, in Gut, vol. 45, Suppl 4, 1999, pp. 1-11, DOI:10.1136/gut.45.2008.iv1, PMC 1766696, PMID 10485854.
(EN) Patch D, Armonis A, Sabin C, et al., Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding, in Gut, vol. 44, n. 2, 1999, pp. 264-9, DOI:10.1136/gut.44.2.264, PMC 1727391, PMID 9895388.

spcare.bmj.com

(EN) Kimbell B, Murray SA, What is the patient experience in advanced liver disease? A scoping review of the literature, in BMJ Support Palliat Care, vol. 5, n. 5, dicembre 2015, pp. 471-80, DOI:10.1136/bmjspcare-2012-000435, PMID 24644180.

books.google.com

(EN) Steven T. Brower, Elective general surgery : an evidence-based approach, New York, McGraw-Hill Medical, 2012, p. 36, ISBN 978-1-60795-109-4 (archiviato l'8 settembre 2017).

cdc.gov

(EN) Anderson RN, Smith BL, Deaths: leading causes for 2001 (PDF), in National Vital Statistics Reports, vol. 52, n. 9, Centers for Disease Control and Prevention, 2003, pp. 1-85, PMID 14626726.

cfp.ca

(EN) Perri GA, Khosravani H, Complications of end-stage liver disease, in Can Fam Physician, vol. 62, n. 1, gennaio 2016, pp. 44-50, PMC 4721840, PMID 26796834.

doi.org

dx.doi.org

(EN) Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 385, n. 9963, 17 dicembre 2014, pp. 117-71, DOI:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442.
(EN) Roguin A, Rene Theophile Hyacinthe Laënnec (1781–1826): The Man Behind the Stethoscope, in Clinical medicine & research, vol. 4, n. 3, 2006, pp. 230-5, DOI:10.3121/cmr.4.3.230, PMC 1570491, PMID 17048358.
(EN) Meirelles Júnior RF, Salvalaggio P, Rezende MB, Evangelista AS, Guardia BD, Matielo CE, Neves DB, Pandullo FL, Felga GE, Alves JA, Curvelo LA, Diaz LG, Rusi MB, Viveiros Mde M, Almeida MD, Pedroso PT, Rocco RA, Meira Filho SP, Liver transplantation: history, outcomes and perspectives, in Einstein (Sao Paulo), vol. 13, n. 1, 2015, pp. 149-52, DOI:10.1590/S1679-45082015RW3164, PMC 4977591, PMID 25993082.
(EN) Collaborators. GBD 2015 Disease and Injury Incidence and Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015., in Lancet, vol. 388, n. 10053, 8 ottobre 2016, pp. 1545-1602, DOI:10.1016/S0140-6736(16)31678-6, PMC 5055577, PMID 27733282.
(EN) Collaborators. GBD 2015 Mortality and Causes of Death, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015., in Lancet, vol. 388, n. 10053, 8 ottobre 2016, pp. 1459-1544, DOI:10.1016/s0140-6736(16)31012-1, PMC 5388903, PMID 27733281.
(EN) Sørensen HT, Thulstrup AM, Mellemkjar L, et al., Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark, in Journal of Clinical Epidemiology, vol. 56, n. 1, 2003, pp. 88-93, DOI:10.1016/S0895-4356(02)00531-0, PMID 12589875.
(EN) Schuppan D, Afdhal NH, Liver cirrhosis, in Lancet, vol. 371, n. 9615, marzo 2008, pp. 838-51, DOI:10.1016/S0140-6736(08)60383-9, PMC 2271178, PMID 18328931.
Mueller S, Millonig G, Seitz HK, Alcoholic liver disease and hepatitis C: a frequently underestimated combination, in World J. Gastroenterol., vol. 15, n. 28, luglio 2009, pp. 3462-71, DOI:10.3748/wjg.15.3462, PMC 2715970, PMID 19630099.
(EN) Klatsky AL, Morton C, Udaltsova N, Friedman GD, Coffee, cirrhosis, and transaminase enzymes, in Archives of Internal Medicine, vol. 166, n. 11, 2006, pp. 1190-5, DOI:10.1001/archinte.166.11.1190, PMID 16772246.
(EN) European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Management of alcohol-related liver disease, in J. Hepatology, vol. 69, luglio 2018, pp. 154-181, DOI:10.1016/j.jhep.2018.03.018.
Toshikuni N, Arisawa T, Tsutsumi M, Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality, in World J. Gastroenterol., vol. 20, n. 11, marzo 2014, pp. 2876-87, DOI:10.3748/wjg.v20.i11.2876, PMC 3961980, PMID 24659879.
KASL clinical practice guidelines: management of chronic hepatitis B, in Clin Mol Hepatol, vol. 22, n. 1, marzo 2016, pp. 18-75, DOI:10.3350/cmh.2016.22.1.18, PMC 4825166, PMID 27044762.
(EN) M.J. Alter, Epidemiology of hepatitis B in Europe and worldwide, in J. Hepatol., vol. 39, Suppl.1, 2003, pp. 64-69, DOI:10.1016/S0168-8278(03)00141-7, PMID 14708680.
(EN) Kingsmore SF, Lindquist IE, Mudge J, Gessler DD, Beavis WD, Genome-wide association studies: progress and potential for drug discovery and development, in Nat Rev Drug Discov, vol. 7, n. 3, marzo 2008, pp. 221-30, DOI:10.1038/nrd2519, PMC 2853477, PMID 18274536.
(EN) T.H. Karlsen, Primary sclerosing cholangitis, in J. Hepatol., vol. 67, dicembre 2017, pp. 1298-1323, DOI:10.1016/j.jhep.2017.07.022.
(EN) K. Boonstra, Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis, in J. Hepatol., vol. 56, maggio 2012, pp. 1181-1188, DOI:10.1016/j.jhep.2011.10.025.
(EN) CQ Edwards e Kushner, JP, Screening for hemochromatosis., in The New England Journal of Medicine, vol. 328, n. 22, 3 giugno 1993, pp. 1616-20, DOI:10.1056/NEJM199306033282208, PMID 8110209.
(EN) Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397-408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
(EN) Björnsson ES, Hepatotoxicity by Drugs: The Most Common Implicated Agents, in Int J Mol Sci, vol. 17, n. 2, febbraio 2016, p. 224, DOI:10.3390/ijms17020224, PMC 4783956, PMID 26861310.
(EN) E. El-Ahwany, New insights in the roadmap of liver fibrosis pathogenesis (PDF), in Egyptian J. Hosp. Med., vol. 54, 2014, pp. 71-87, DOI:10.12816/0002433.
Zhou WC, Zhang QB, Qiao L, Pathogenesis of liver cirrhosis, in World J. Gastroenterol., vol. 20, n. 23, giugno 2014, pp. 7312-24, DOI:10.3748/wjg.v20.i23.7312, PMC 4064077, PMID 24966602.
(EN) Giallourakis CC, Rosenberg PM, Friedman LS, The liver in heart failure, in Clin Liver Dis, vol. 6, n. 4, novembre 2002, pp. 947–67, viii–ix, DOI:10.1016/S1089-3261(02)00056-9, PMID 12516201.
(EN) Heathcote EJ, Primary biliary cirrhosis: historical perspective, in Clin Liver Dis, vol. 7, n. 4, novembre 2003, pp. 735-40, DOI:10.1016/S1089-3261(03)00098-9, PMID 14594128.
(EN) Nolte W, Hartmann H, Ramadori G, Glucose metabolism and liver cirrhosis, in Exp. Clin. Endocrinol. Diabetes, vol. 103, n. 2, 1995, pp. 63-74, DOI:10.1055/s-0029-1211331, PMID 7553077.
(EN) Sauerbruch T, Schierwagen R, Trebicka J, Managing portal hypertension in patients with liver cirrhosis, in F1000Res, vol. 7, 2018, DOI:10.12688/f1000research.13943.1, PMC 5934688, PMID 29780579.
(EN) Moore KP, Aithal GP, Guidelines on the management of ascites in cirrhosis, in Gut, 55 Suppl 6, Suppl 6, ottobre 2006, pp. vi1–12, DOI:10.1136/gut.2006.099580, PMC 1860002, PMID 16966752.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Singal AG, Pillai A, Tiro J, Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis, in PLoS Med, vol. 11, n. 4, 2014, pp. e1001624, DOI:10.1371/journal.pmed.1001624, PMC 3972088, PMID 24691105.
(EN) von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M, Portal vein thrombosis in patients with cirrhosis, in Gastroenterol Rep (Oxf), vol. 5, n. 2, maggio 2017, pp. 148-156, DOI:10.1093/gastro/gox014, PMC 5421355, PMID 28533912.
(EN) Riordan SM, Williams R, The intestinal flora and bacterial infection in cirrhosis, in J. Hepatol., vol. 45, n. 5, novembre 2006, pp. 744-57, DOI:10.1016/j.jhep.2006.08.001, PMID 16979776.
(EN) A Grant, Neuberger J, Guidelines on the use of liver biopsy in clinical practice, in Gut, vol. 45, Suppl 4, 1999, pp. 1-11, DOI:10.1136/gut.45.2008.iv1, PMC 1766696, PMID 10485854.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E, Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: the Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) Adinolfi LE, Nevola R, Rinaldi L, Romano C, Giordano M, Chronic Hepatitis C Virus Infection and Depression, in Clin Liver Dis, vol. 21, n. 3, agosto 2017, pp. 517-534, DOI:10.1016/j.cld.2017.03.007, PMID 28689590.
(EN) Manning DS, Afdhal NH, Diagnosis and quantitation of fibrosis, in Gastroenterology, vol. 134, n. 6, maggio 2008, pp. 1670-81, DOI:10.1053/j.gastro.2008.03.001, PMID 18471546.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E e Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: The Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski e Lech Chrostek, Selected Noninvasive Markers in Diagnosing Liver Diseases, in Laboratory Medicine, vol. 47, n. 1, 2016, pp. 67-72, DOI:10.1093/labmed/lmv015, ISSN 0007-5027 (WC · ACNP).
(EN) Halfon P, Munteanu M, Poynard T, FibroTest-ActiTest as a non-invasive marker of liver ﬁbrosis, in Gastroenterol Clin Biol, vol. 32, n. 6, settembre 2008, pp. 22-39, DOI:10.1016/S0399-8320(08)73991-5, PMID 18973844.
(EN) Himoto T, Nishioka M, Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis, in Auto Immun Highlights, vol. 4, n. 2, agosto 2013, pp. 39-53, DOI:10.1007/s13317-013-0046-7, PMC 4389052, PMID 26000142.
(EN) Chrostek L, Supronowicz L, Panasiuk A, Cylwik B, Gruszewska E, Flisiak R, The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins, in Clin. Exp. Med., vol. 14, n. 4, novembre 2014, pp. 417-21, DOI:10.1007/s10238-013-0262-5, PMC 4213382, PMID 24122348.
(EN) Al-Jameil N, Hassan AA, Buhairan A, Hassanato R, Isac SR, Al-Otaiby M, Al-Maarik B, Al-Ajeyan I, Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis, in Medicine (Baltimore), vol. 96, n. 6, febbraio 2017, pp. e6071, DOI:10.1097/MD.0000000000006071, PMC 5313019, PMID 28178162.
(EN) Giunta M, Conte D, Fraquelli M, Role of spleen elastography in patients with chronic liver diseases, in World J. Gastroenterol., vol. 22, n. 35, settembre 2016, pp. 7857-67, DOI:10.3748/wjg.v22.i35.7857, PMC 5028802, PMID 27672283.
(EN) Jiang H, Zheng T, Duan T, Chen J, Song B, Non-invasive in vivo Imaging Grading of Liver Fibrosis, in J Clin Transl Hepatol, vol. 6, n. 2, giugno 2018, pp. 198-207, DOI:10.14218/JCTH.2017.00038, PMC 6018309, PMID 29951365.
(EN) Hennedige T, Venkatesh SK, Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring, in Cancer Imaging, vol. 12, febbraio 2013, pp. 530-47, DOI:10.1102/1470-7330.2012.0044, PMC 3666429, PMID 23400006.
(EN) Martens P, Nevens F, Budd-Chiari syndrome, in United European Gastroenterol J, vol. 3, n. 6, dicembre 2015, pp. 489-500, DOI:10.1177/2050640615582293, PMC 4669515, PMID 26668741.
(EN) Iranpour P, Lall C, Houshyar R, Helmy M, Yang A, Choi JI, Ward G, Goodwin SC, Altered Doppler flow patterns in cirrhosis patients: an overview, in Ultrasonography, vol. 35, n. 1, gennaio 2016, pp. 3-12, DOI:10.14366/usg.15020, PMC 4701371, PMID 26169079.
(EN) Maruyama H, Yokosuka O, Ultrasonography for Noninvasive Assessment of Portal Hypertension, in Gut Liver, vol. 11, n. 4, luglio 2017, pp. 464-473, DOI:10.5009/gnl16078, PMC 5491080, PMID 28267700.
(EN) Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V, Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C, in Gastroenterology, vol. 140, n. 7, giugno 2011, pp. 1970–9, 1979.e1–3, DOI:10.1053/j.gastro.2011.02.058, PMID 21376047.
(EN) Foucher J, Chanteloup E, Vergniol J, et al., Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, in Gut, vol. 55, n. 3, 2006, pp. 403-8, DOI:10.1136/gut.2005.069153, PMC 1856085, PMID 16020491.
(EN) Talakić E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, Schoellnast H, CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?, in Eur Radiol, vol. 27, n. 10, ottobre 2017, pp. 4173-4180, DOI:10.1007/s00330-017-4788-x, PMC 5579174, PMID 28321540.
(EN) Van Beers BE, Pastor CM, Hussain HK, Primovist, Eovist: what to expect?, in J. Hepatol., vol. 57, n. 2, agosto 2012, pp. 421-9, DOI:10.1016/j.jhep.2012.01.031, PMID 22504332.
(EN) Cho SH, Kang UR, Kim JD, Han YS, Choi DL, The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study, in Eur J Radiol, vol. 80, n. 2, novembre 2011, pp. e195–200, DOI:10.1016/j.ejrad.2011.08.008, PMID 21908121.
(EN) Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, Doi K, Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging, in Radiology, vol. 260, n. 3, settembre 2011, pp. 727-33, DOI:10.1148/radiol.11100586, PMID 21712472.
(EN) Mathew RP, Venkatesh SK, Imaging of Hepatic Fibrosis, in Curr Gastroenterol Rep, vol. 20, n. 10, agosto 2018, p. 45, DOI:10.1007/s11894-018-0652-7, PMID 30159792.
(EN) Keller S, Sedlacik J, Schuler T, Buchert R, Avanesov M, Zenouzi R, Lohse AW, Kooijman H, Fiehler J, Schramm C, Yamamura J, Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis, in Eur Radiol, luglio 2018, DOI:10.1007/s00330-018-5614-9, PMID 30014204.
(EN) Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G, Sirlin CB, MR imaging of liver fibrosis: current state of the art, in Radiographics, vol. 29, n. 6, ottobre 2009, pp. 1615-35, DOI:10.1148/rg.296095512, PMID 19959511.
(EN) Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM, Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence, in Radiology, vol. 181, n. 3, dicembre 1991, pp. 805-8, DOI:10.1148/radiology.181.3.1947101, PMID 1947101. URL consultato il 12 marzo 2018.
(EN) Venkatesh SK, Talwalkar JA, When and how to use magnetic resonance elastography for patients with liver disease in clinical practice, in Am. J. Gastroenterol., vol. 113, n. 7, luglio 2018, pp. 923-926, DOI:10.1038/s41395-018-0012-0, PMID 29487410.
(EN) Chakraborty D, Sunil HV, Mittal BR, Bhattacharya A, Singh B, Chawla Y, Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver, in Indian J Nucl Med, vol. 25, n. 4, ottobre 2010, pp. 139-42, DOI:10.4103/0972-3919.78247, PMC 3109819, PMID 21713221.
(EN) Krystallis C, Masterton GS, Hayes PC, Plevris JN, Update of endoscopy in liver disease: more than just treating varices, in World J. Gastroenterol., vol. 18, n. 5, febbraio 2012, pp. 401-11, DOI:10.3748/wjg.v18.i5.401, PMC 3272639, PMID 22346246.
(EN) Simon K, Orłowska I, Pazgan-Simon M, The risk of complications of endoscopic procedures in patients with liver cirrhosis, in Clin Exp Hepatol, vol. 3, n. 3, settembre 2017, pp. 135-140, DOI:10.5114/ceh.2017.70284, PMC 5649487, PMID 29062903.
(EN) Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Transection of the oesophagus for bleeding oesophageal varices, in Br J Surg, vol. 60, n. 8, 1973, pp. 646-9, DOI:10.1002/bjs.1800600817, PMID 4541913.
(EN) M. Malinchoc, PS. Kamath; FD. Gordon; CJ. Peine; J. Rank; PC. ter Borg, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts., in Hepatology, vol. 31, n. 4, aprile 2000, pp. 864-71, DOI:10.1053/he.2000.5852, PMID 10733541.
(EN) PS. Kamath, WR. Kim, The model for end-stage liver disease (MELD)., in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) Patch D, Armonis A, Sabin C, et al., Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding, in Gut, vol. 44, n. 2, 1999, pp. 264-9, DOI:10.1136/gut.44.2.264, PMC 1727391, PMID 9895388.
(EN) Chandok N, Watt KD, Pain management in the cirrhotic patient: the clinical challenge, in Mayo Clin. Proc., vol. 85, n. 5, maggio 2010, pp. 451-8, DOI:10.4065/mcp.2009.0534, PMC 2861975, PMID 20357277.
(EN) Hong YM, Yoon KT, Heo J, Woo HY, Lim W, An DS, Han JH, Cho M, The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis, in J. Korean Med. Sci., vol. 31, n. 10, ottobre 2016, pp. 1604-10, DOI:10.3346/jkms.2016.31.10.1604, PMC 4999403, PMID 27550489.
(EN) Toshikuni N, Arisawa T, Tsutsumi M, Nutrition and exercise in the management of liver cirrhosis, in World J. Gastroenterol., vol. 20, n. 23, giugno 2014, pp. 7286-97, DOI:10.3748/wjg.v20.i23.7286, PMC 4064074, PMID 24966599.
(EN) Nusrat S, Khan MS, Fazili J, Madhoun MF, Cirrhosis and its complications: evidence based treatment, in World J. Gastroenterol., vol. 20, n. 18, maggio 2014, pp. 5442-60, DOI:10.3748/wjg.v20.i18.5442, PMC 4017060, PMID 24833875.
(EN) NC Chavez-Tapia, T Barrientos-Gutierrez, FI Tellez-Avila, K Soares-Weiser e M Uribe, Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding., in The Cochrane Database of Systematic Reviews, n. 9, 8 settembre 2010, pp. CD002907, DOI:10.1002/14651858.CD002907.pub2, PMID 20824832.
(EN) Moctezuma-Velazquez C, Kalainy S, Abraldes JG, Beta-blockers in patients with advanced liver disease: Has the dust settled?, in Liver Transpl., vol. 23, n. 8, agosto 2017, pp. 1058-1069, DOI:10.1002/lt.24794, PMID 28590564.
(EN) Kamath PS, Kim WR, The model for end-stage liver disease (MELD), in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P, Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals, in J. Hepatol., settembre 2018, DOI:10.1016/j.jhep.2018.08.028, PMID 30243996.
(EN) Kimbell B, Murray SA, What is the patient experience in advanced liver disease? A scoping review of the literature, in BMJ Support Palliat Care, vol. 5, n. 5, dicembre 2015, pp. 471-80, DOI:10.1136/bmjspcare-2012-000435, PMID 24644180.
(EN) Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ, Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation, in J Pain Symptom Manage, vol. 50, n. 6, dicembre 2015, pp. 882–6.e2, DOI:10.1016/j.jpainsymman.2015.07.014, PMID 26303186.
(EN) W Sanchez e JA Talwalkar, Palliative care for patients with end-stage liver disease ineligible for liver transplantation., in Gastroenterology clinics of North America, vol. 35, n. 1, marzo 2006, pp. 201-19, DOI:10.1016/j.gtc.2005.12.007, PMID 16530121.
(EN) Z Poonja, A Brisebois, SV van Zanten, P Tandon, G Meeberg e CJ Karvellas, Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management., in Clinical Gastroenterology and Hepatology, vol. 12, n. 4, aprile 2014, pp. 692-8, DOI:10.1016/j.cgh.2013.08.027, PMID 23978345.
(EN) E Cholongitas, Papatheodoridis, GV, Vangeli, M, Terreni, N, Patch, D e Burroughs, AK, Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, in Alimentary Pharmacology & Therapeutics, vol. 22, n. 11-12, dicembre 2005, pp. 1079-89, DOI:10.1111/j.1365-2036.2005.02691.x/full, PMID 16305721.

doi.org

(EN) Moctezuma-Velazquez C, Kalainy S, Abraldes JG, Beta-blockers in patients with advanced liver disease: Has the dust settled?, in Liver Transpl., vol. 23, n. 8, agosto 2017, pp. 1058-1069, DOI:10.1002/lt.24794, PMID 28590564.

easl.eu

(EN) European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Autoimmune hepatitis (PDF), in J. Hepatol., vol. 63, 2015, pp. 971-1004, PMID 26341719.

egyptianjournal.xyz

(EN) E. El-Ahwany, New insights in the roadmap of liver fibrosis pathogenesis (PDF), in Egyptian J. Hosp. Med., vol. 54, 2014, pp. 71-87, DOI:10.12816/0002433.

emedicinehealth.com

(EN) E-medicine liver transplant outlook and survival rates, su emedicinehealth.com, 9 giugno 2009. URL consultato il 6 settembre 2009 (archiviato il 14 luglio 2009).

f1000research.com

(EN) Sauerbruch T, Schierwagen R, Trebicka J, Managing portal hypertension in patients with liver cirrhosis, in F1000Res, vol. 7, 2018, DOI:10.12688/f1000research.13943.1, PMC 5934688, PMID 29780579.

google.it

books.google.it

G. Levi, Enciclopedia delle scienze mediche, vol. 2, 1842, p. 320.
(EN) Giles W. Boland, Gastrointestinal Imaging: The Requisite, Elsevier Health Sciences, 2013, p. 232, ISBN 978-0-323-10199-8.

gutnliver.org

(EN) Maruyama H, Yokosuka O, Ultrasonography for Noninvasive Assessment of Portal Hypertension, in Gut Liver, vol. 11, n. 4, luglio 2017, pp. 464-473, DOI:10.5009/gnl16078, PMC 5491080, PMID 28267700.

ijnm.in

(EN) Chakraborty D, Sunil HV, Mittal BR, Bhattacharya A, Singh B, Chawla Y, Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver, in Indian J Nucl Med, vol. 25, n. 4, ottobre 2010, pp. 139-42, DOI:10.4103/0972-3919.78247, PMC 3109819, PMID 21713221.

iss.it

epicentro.iss.it

Osservatorio nazionale alcol, su epicentro.iss.it. URL consultato il 28 luglio 2019.

istat.it

Report ISTAT, L'evoluzione della mortalità per causa: le prime 25 cause di morte (PDF), 2017.

jamanetwork.com

(EN) Warren SE, Mitas JA, Swerdlin AH, Hypernatremia in hepatic failure, in JAMA, vol. 243, n. 12, marzo 1980, pp. 1257-60, PMID 7359682.

jkms.org

(EN) Hong YM, Yoon KT, Heo J, Woo HY, Lim W, An DS, Han JH, Cho M, The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis, in J. Korean Med. Sci., vol. 31, n. 10, ottobre 2016, pp. 1604-10, DOI:10.3346/jkms.2016.31.10.1604, PMC 4999403, PMID 27550489.

journal-of-hepatology.eu

(EN) European Association for the Study of Liver, EASL clinical practical guidelines: management of alcoholic liver disease, in J. Hepatol., vol. 57, 2012, pp. 399-420, PMID 22633836.
(EN) European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Management of alcohol-related liver disease, in J. Hepatology, vol. 69, luglio 2018, pp. 154-181, DOI:10.1016/j.jhep.2018.03.018.
(EN) M.J. Alter, Epidemiology of hepatitis B in Europe and worldwide, in J. Hepatol., vol. 39, Suppl.1, 2003, pp. 64-69, DOI:10.1016/S0168-8278(03)00141-7, PMID 14708680.
(EN) T.H. Karlsen, Primary sclerosing cholangitis, in J. Hepatol., vol. 67, dicembre 2017, pp. 1298-1323, DOI:10.1016/j.jhep.2017.07.022.
(EN) K. Boonstra, Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis, in J. Hepatol., vol. 56, maggio 2012, pp. 1181-1188, DOI:10.1016/j.jhep.2011.10.025.

mayoclinic.org

(EN) Cirrhosis, su mayoclinic.org, Mayo Clinic. URL consultato il 25 settembre 2018.

mdpi.com

(EN) Björnsson ES, Hepatotoxicity by Drugs: The Most Common Implicated Agents, in Int J Mol Sci, vol. 17, n. 2, febbraio 2016, p. 224, DOI:10.3390/ijms17020224, PMC 4783956, PMID 26861310.

nature.com

(EN) V. Bagnardi, Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis, in British J. Cancer, vol. 112, 2015, pp. 580-593, PMID 25422909.
(EN) B. Hajarizadeh, Epidemiology and natural history of HCV infection (abstract), in Nature Rev. Gastroenterol. Hepatol., vol. 10, 2013, pp. 553-562, PMID 23817321.

nhs.uk

(EN) National Health Service, Overview - Cirrhosis, su nhs.uk. URL consultato il 2 novembre 2018.

nih.gov

ncbi.nlm.nih.gov

(EN) Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 385, n. 9963, 17 dicembre 2014, pp. 117-71, DOI:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442.
(EN) J.M. Duffin, Why does cirrhosis belong to Laennec? (PDF), in CMAJ, vol. 137, 1987, pp. 393-396, PMID 3304599.
(EN) Roguin A, Rene Theophile Hyacinthe Laënnec (1781–1826): The Man Behind the Stethoscope, in Clinical medicine & research, vol. 4, n. 3, 2006, pp. 230-5, DOI:10.3121/cmr.4.3.230, PMC 1570491, PMID 17048358.
(EN) Meirelles Júnior RF, Salvalaggio P, Rezende MB, Evangelista AS, Guardia BD, Matielo CE, Neves DB, Pandullo FL, Felga GE, Alves JA, Curvelo LA, Diaz LG, Rusi MB, Viveiros Mde M, Almeida MD, Pedroso PT, Rocco RA, Meira Filho SP, Liver transplantation: history, outcomes and perspectives, in Einstein (Sao Paulo), vol. 13, n. 1, 2015, pp. 149-52, DOI:10.1590/S1679-45082015RW3164, PMC 4977591, PMID 25993082.
(EN) Collaborators. GBD 2015 Disease and Injury Incidence and Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015., in Lancet, vol. 388, n. 10053, 8 ottobre 2016, pp. 1545-1602, DOI:10.1016/S0140-6736(16)31678-6, PMC 5055577, PMID 27733282.
(EN) Collaborators. GBD 2015 Mortality and Causes of Death, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015., in Lancet, vol. 388, n. 10053, 8 ottobre 2016, pp. 1459-1544, DOI:10.1016/s0140-6736(16)31012-1, PMC 5388903, PMID 27733281.
(EN) Anderson RN, Smith BL, Deaths: leading causes for 2001 (PDF), in National Vital Statistics Reports, vol. 52, n. 9, Centers for Disease Control and Prevention, 2003, pp. 1-85, PMID 14626726.
(EN) Sørensen HT, Thulstrup AM, Mellemkjar L, et al., Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark, in Journal of Clinical Epidemiology, vol. 56, n. 1, 2003, pp. 88-93, DOI:10.1016/S0895-4356(02)00531-0, PMID 12589875.
(EN) European Association for the Study of Liver, EASL clinical practical guidelines: management of alcoholic liver disease, in J. Hepatol., vol. 57, 2012, pp. 399-420, PMID 22633836.
(EN) C.J. Murray, The global burden of disease in 1990: summary results, sensitivity analysis and future directions, in Bull. World Health Organ., vol. 72, 1994, pp. 495-509, PMID 8062404.
(EN) C.J. Murray, Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 (abstract), in Lancet, vol. 380, 2012, pp. 2197-2223, PMID 23245608.
(EN) J. Rehm, Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders (abstract), in Lancet, vol. 373, 2009, pp. 2223-2233, PMID 19560604.
Neff GW, Duncan CW, Schiff ER, The current economic burden of cirrhosis, in Gastroenterol Hepatol (N Y), vol. 7, n. 10, ottobre 2011, pp. 661-71, PMC 3265008, PMID 22298959.
(EN) Schuppan D, Afdhal NH, Liver cirrhosis, in Lancet, vol. 371, n. 9615, marzo 2008, pp. 838-51, DOI:10.1016/S0140-6736(08)60383-9, PMC 2271178, PMID 18328931.
(EN) Detlef Schuppan e Nezam Afdhal, Hepatic Cirrhosis, su ncbi.nlm.nih.gov. URL consultato il 30 luglio 2019.
Mueller S, Millonig G, Seitz HK, Alcoholic liver disease and hepatitis C: a frequently underestimated combination, in World J. Gastroenterol., vol. 15, n. 28, luglio 2009, pp. 3462-71, DOI:10.3748/wjg.15.3462, PMC 2715970, PMID 19630099.
(EN) Klatsky AL, Morton C, Udaltsova N, Friedman GD, Coffee, cirrhosis, and transaminase enzymes, in Archives of Internal Medicine, vol. 166, n. 11, 2006, pp. 1190-5, DOI:10.1001/archinte.166.11.1190, PMID 16772246.
(EN) U. Becker, Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study (abstract), in Hepatology, vol. 23, 1996, pp. 1025-1029, PMID 8621128.
(EN) G. Corrao, Meta-analysis of alcohol intake in relation to risk of liver cirrhosis (abstract), in Alcohol Alcohol, vol. 33, 1998, pp. 381-392, PMID 9719397.
(EN) J. Rehm, Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis (abstract), in Drug Alcohol Rev., vol. 29, 2010, pp. 437-445, PMID 20636661.
(EN) Piano MR, Alcohol's Effects on the Cardiovascular System, in Alcohol Res, vol. 38, n. 2, 2017, pp. 219-241, PMC 5513687, PMID 28988575.
(EN) V. Bagnardi, Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis, in British J. Cancer, vol. 112, 2015, pp. 580-593, PMID 25422909.
(EN) E.S. Orman, Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy, in J. Gastroentero.l Hepatol., vol. 28, 2013, pp. 77-84, PMID 23855300.
(EN) E.J. Raff, Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases, in J. Clin. Transl. Hepatol., vol. 3, 2015, pp. 9-16, PMID 26356325.
Toshikuni N, Arisawa T, Tsutsumi M, Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality, in World J. Gastroenterol., vol. 20, n. 11, marzo 2014, pp. 2876-87, DOI:10.3748/wjg.v20.i11.2876, PMC 3961980, PMID 24659879.
KASL clinical practice guidelines: management of chronic hepatitis B, in Clin Mol Hepatol, vol. 22, n. 1, marzo 2016, pp. 18-75, DOI:10.3350/cmh.2016.22.1.18, PMC 4825166, PMID 27044762.
(EN) M.J. Alter, Epidemiology of hepatitis B in Europe and worldwide, in J. Hepatol., vol. 39, Suppl.1, 2003, pp. 64-69, DOI:10.1016/S0168-8278(03)00141-7, PMID 14708680.
(EN) J. Hou, Epidemiology and Prevention of Hepatitis B Virus Infection, in Int. J. Med. Sci., vol. 2, 2005, PMID 15968340.
(EN) J.H. MacLachlan, Hepatitis B Virus Epidemiology, in Cold Spring Harb. Perspect. Med., vol. 5, 2015, p. a021410, PMID 25934461.
(EN) M.J. Alter, Epidemiology of hepatitis C virus infection, in World J. Gastroenterol., vol. 13, 2007, pp. 2436-2441, PMID 17552026.
(EN) B. Hajarizadeh, Epidemiology and natural history of HCV infection (abstract), in Nature Rev. Gastroenterol. Hepatol., vol. 10, 2013, pp. 553-562, PMID 23817321.
(EN) Kingsmore SF, Lindquist IE, Mudge J, Gessler DD, Beavis WD, Genome-wide association studies: progress and potential for drug discovery and development, in Nat Rev Drug Discov, vol. 7, n. 3, marzo 2008, pp. 221-30, DOI:10.1038/nrd2519, PMC 2853477, PMID 18274536.
(EN) T. Nakazawa, Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?, in World J. Gastroenterol., vol. 20, 2014, pp. 3245-3254, PMID 24696608.
(EN) European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Autoimmune hepatitis (PDF), in J. Hepatol., vol. 63, 2015, pp. 971-1004, PMID 26341719.
(EN) A. Siddique, Review article: the iron overload syndromes, in Aliment. Pharmacol. Ther., vol. 35, 2012, pp. 876-893, PMID 22385471.
(EN) M. Franchini, Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment, in Am. J. Hematol., vol. 81, 2006, pp. 202-209, PMID 16493621.
(EN) CQ Edwards e Kushner, JP, Screening for hemochromatosis., in The New England Journal of Medicine, vol. 328, n. 22, 3 giugno 1993, pp. 1616-20, DOI:10.1056/NEJM199306033282208, PMID 8110209.
(EN) Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397-408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
(EN) European Association, EASL Clinical Practice Guidelines: Wilson’s disease (PDF), in J. Hepatol., vol. 56, 2012, pp. 671-685, PMID 22340672. URL consultato il 25 novembre 2018 (archiviato dall'url originale il 23 novembre 2018).
(EN) T. Sveger, The natural history of liver disease in alpha 1-antitrypsin deficient children (abstract), in Acta Paediatr. Scand., vol. 77, 1988, pp. 847-851, PMID 2905108.
(EN) M.F. Dawwas, Prevalence and Risk Factors for Liver Involvement in Individuals with PiZZ-related Lung Disease, in Am. J. Respir. Crit. Care Med., vol. 187, 2013, PMID 23262512.
(EN) MS Tanner, Role of copper in Indian childhood cirrhosis., in The American Journal of Clinical Nutrition, vol. 67, 5 Suppl, maggio 1998, pp. 1074S-1081S, PMID 9587155.
(EN) Medline A, Medline NM, Galactosemia: early structural changes in the liver, in Can Med Assoc J, vol. 107, n. 9, novembre 1972, pp. 877-8, PMC 1940825, PMID 4653934.
(DE) Vogt M, Gitzelmann R, Allemann J, [Decompensated liver cirrhosis caused by galactosemia in a 52-year-old man], in Schweiz Med Wochenschr, vol. 110, n. 47, novembre 1980, pp. 1781-3, PMID 7455652.
ANDERSEN DH, Familial cirrhosis of the liver with storage of abnormal glycogen, in Lab. Invest., vol. 5, n. 1, 1956, pp. 11-20, PMID 13279125.
(EN) Björnsson ES, Hepatotoxicity by Drugs: The Most Common Implicated Agents, in Int J Mol Sci, vol. 17, n. 2, febbraio 2016, p. 224, DOI:10.3390/ijms17020224, PMC 4783956, PMID 26861310.
(EN) R. Bataller, Liver fibrosis, in J. Clin. Inv., vol. 115, 2005, pp. 209-218, PMID 15690074.
(EN) G.O. Elpek, Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update, in World J Gastroenterol., vol. 20, 2014, pp. 7260-7276, PMID 24966597.
(EN) S.L. Friedman, Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver, in Physiol. Rev., vol. 88, 2008, pp. 125-172, PMID 18195085.
Zhou WC, Zhang QB, Qiao L, Pathogenesis of liver cirrhosis, in World J. Gastroenterol., vol. 20, n. 23, giugno 2014, pp. 7312-24, DOI:10.3748/wjg.v20.i23.7312, PMC 4064077, PMID 24966602.
(EN) Y.K. Jung, Reversal of liver cirrhosis: current evidence and expectations, in Korean J. Intern. Med., vol. 32, 2017, pp. 213-228, PMID 28171717.
(EN) H. Ebrahimi, New concepts on reversibility and targeting of liver fibrosis; a review article, in Middle East J. Dig. Dis., vol. 10, 2018, pp. 133-148, PMID 30186577.
(EN) Z. Almpanis, Evaluation of liver fibrosis: “Something old, something new…”, in Ann. Gastroenterol., vol. 29, 2016, pp. 445-453, PMID 27708509.
(EN) M.Y. Kim, Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension (abstract), in J. Hepatol., vol. 55, 2011, pp. 1004-1009, PMID 21354227.
(EN) C.L. Regina, Histopathological evaluation of liver fibrosis and cirrhosis regression, in Clin. Mol. Hepatol., vol. 23, 2017, pp. 302-307, PMID 29281870.
(EN) Giallourakis CC, Rosenberg PM, Friedman LS, The liver in heart failure, in Clin Liver Dis, vol. 6, n. 4, novembre 2002, pp. 947–67, viii–ix, DOI:10.1016/S1089-3261(02)00056-9, PMID 12516201.
(EN) Heathcote EJ, Primary biliary cirrhosis: historical perspective, in Clin Liver Dis, vol. 7, n. 4, novembre 2003, pp. 735-40, DOI:10.1016/S1089-3261(03)00098-9, PMID 14594128.
(EN) Nolte W, Hartmann H, Ramadori G, Glucose metabolism and liver cirrhosis, in Exp. Clin. Endocrinol. Diabetes, vol. 103, n. 2, 1995, pp. 63-74, DOI:10.1055/s-0029-1211331, PMID 7553077.
(EN) Sauerbruch T, Schierwagen R, Trebicka J, Managing portal hypertension in patients with liver cirrhosis, in F1000Res, vol. 7, 2018, DOI:10.12688/f1000research.13943.1, PMC 5934688, PMID 29780579.
(EN) Moore KP, Aithal GP, Guidelines on the management of ascites in cirrhosis, in Gut, 55 Suppl 6, Suppl 6, ottobre 2006, pp. vi1–12, DOI:10.1136/gut.2006.099580, PMC 1860002, PMID 16966752.
(EN) Arroyo V, Navasa M, Rimola A, Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis, in Infection, 22 Suppl 3, 1994, pp. S167–75, PMID 7843826.
(EN) Odelowo OO, Smoot DT, Kim K, Upper gastrointestinal bleeding in patients with liver cirrhosis, in J Natl Med Assoc, vol. 94, n. 8, agosto 2002, pp. 712-5, PMC 2594284, PMID 12152928.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Ginés P, Arroyo V, Quintero E, Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study, in Gastroenterology, vol. 93, n. 2, 1987, pp. 234-41, PMID 3297907.
(EN) Singal AG, Pillai A, Tiro J, Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis, in PLoS Med, vol. 11, n. 4, 2014, pp. e1001624, DOI:10.1371/journal.pmed.1001624, PMC 3972088, PMID 24691105.
(EN) von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M, Portal vein thrombosis in patients with cirrhosis, in Gastroenterol Rep (Oxf), vol. 5, n. 2, maggio 2017, pp. 148-156, DOI:10.1093/gastro/gox014, PMC 5421355, PMID 28533912.
(EN) Riordan SM, Williams R, The intestinal flora and bacterial infection in cirrhosis, in J. Hepatol., vol. 45, n. 5, novembre 2006, pp. 744-57, DOI:10.1016/j.jhep.2006.08.001, PMID 16979776.
(EN) A Grant, Neuberger J, Guidelines on the use of liver biopsy in clinical practice, in Gut, vol. 45, Suppl 4, 1999, pp. 1-11, DOI:10.1136/gut.45.2008.iv1, PMC 1766696, PMID 10485854.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E, Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: the Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) de Bruyn G, Graviss EA, A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis, in BMC Med Inform Decis Mak, vol. 1, 2001, p. 6, PMC 64783, PMID 11806763.
(EN) Adinolfi LE, Nevola R, Rinaldi L, Romano C, Giordano M, Chronic Hepatitis C Virus Infection and Depression, in Clin Liver Dis, vol. 21, n. 3, agosto 2017, pp. 517-534, DOI:10.1016/j.cld.2017.03.007, PMID 28689590.
(EN) Manning DS, Afdhal NH, Diagnosis and quantitation of fibrosis, in Gastroenterology, vol. 134, n. 6, maggio 2008, pp. 1670-81, DOI:10.1053/j.gastro.2008.03.001, PMID 18471546.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E e Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: The Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) Qamar AA, Grace ND, Abnormal hematological indices in cirrhosis, in Can. J. Gastroenterol., vol. 23, n. 6, giugno 2009, pp. 441-5, PMC 2721814, PMID 19543577.
(EN) Jaiswal G, Deo V, Bhongade M, Jaiswal S, Serum alkaline phosphatase: a potential marker in the progression of periodontal disease in cirrhosis patients, in Quintessence Int, vol. 42, n. 4, aprile 2011, pp. 345-8, PMID 21516281.
(EN) Johnston DE, Special considerations in interpreting liver function tests, in Am Fam Physician, vol. 59, n. 8, aprile 1999, pp. 2223-30, PMID 10221307.
(EN) Warren SE, Mitas JA, Swerdlin AH, Hypernatremia in hepatic failure, in JAMA, vol. 243, n. 12, marzo 1980, pp. 1257-60, PMID 7359682.
(EN) Halfon P, Munteanu M, Poynard T, FibroTest-ActiTest as a non-invasive marker of liver ﬁbrosis, in Gastroenterol Clin Biol, vol. 32, n. 6, settembre 2008, pp. 22-39, DOI:10.1016/S0399-8320(08)73991-5, PMID 18973844.
(EN) Himoto T, Nishioka M, Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis, in Auto Immun Highlights, vol. 4, n. 2, agosto 2013, pp. 39-53, DOI:10.1007/s13317-013-0046-7, PMC 4389052, PMID 26000142.
(EN) Chrostek L, Supronowicz L, Panasiuk A, Cylwik B, Gruszewska E, Flisiak R, The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins, in Clin. Exp. Med., vol. 14, n. 4, novembre 2014, pp. 417-21, DOI:10.1007/s10238-013-0262-5, PMC 4213382, PMID 24122348.
(EN) Al-Jameil N, Hassan AA, Buhairan A, Hassanato R, Isac SR, Al-Otaiby M, Al-Maarik B, Al-Ajeyan I, Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis, in Medicine (Baltimore), vol. 96, n. 6, febbraio 2017, pp. e6071, DOI:10.1097/MD.0000000000006071, PMC 5313019, PMID 28178162.
(EN) Giunta M, Conte D, Fraquelli M, Role of spleen elastography in patients with chronic liver diseases, in World J. Gastroenterol., vol. 22, n. 35, settembre 2016, pp. 7857-67, DOI:10.3748/wjg.v22.i35.7857, PMC 5028802, PMID 27672283.
(EN) Jiang H, Zheng T, Duan T, Chen J, Song B, Non-invasive in vivo Imaging Grading of Liver Fibrosis, in J Clin Transl Hepatol, vol. 6, n. 2, giugno 2018, pp. 198-207, DOI:10.14218/JCTH.2017.00038, PMC 6018309, PMID 29951365.
(EN) Hennedige T, Venkatesh SK, Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring, in Cancer Imaging, vol. 12, febbraio 2013, pp. 530-47, DOI:10.1102/1470-7330.2012.0044, PMC 3666429, PMID 23400006.
(EN) Martens P, Nevens F, Budd-Chiari syndrome, in United European Gastroenterol J, vol. 3, n. 6, dicembre 2015, pp. 489-500, DOI:10.1177/2050640615582293, PMC 4669515, PMID 26668741.
(EN) Iranpour P, Lall C, Houshyar R, Helmy M, Yang A, Choi JI, Ward G, Goodwin SC, Altered Doppler flow patterns in cirrhosis patients: an overview, in Ultrasonography, vol. 35, n. 1, gennaio 2016, pp. 3-12, DOI:10.14366/usg.15020, PMC 4701371, PMID 26169079.
(EN) Maruyama H, Yokosuka O, Ultrasonography for Noninvasive Assessment of Portal Hypertension, in Gut Liver, vol. 11, n. 4, luglio 2017, pp. 464-473, DOI:10.5009/gnl16078, PMC 5491080, PMID 28267700.
(EN) Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V, Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C, in Gastroenterology, vol. 140, n. 7, giugno 2011, pp. 1970–9, 1979.e1–3, DOI:10.1053/j.gastro.2011.02.058, PMID 21376047.
(EN) Foucher J, Chanteloup E, Vergniol J, et al., Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study, in Gut, vol. 55, n. 3, 2006, pp. 403-8, DOI:10.1136/gut.2005.069153, PMC 1856085, PMID 16020491.
(EN) Talakić E, Schaffellner S, Kniepeiss D, Mueller H, Stauber R, Quehenberger F, Schoellnast H, CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?, in Eur Radiol, vol. 27, n. 10, ottobre 2017, pp. 4173-4180, DOI:10.1007/s00330-017-4788-x, PMC 5579174, PMID 28321540.
(EN) Van Beers BE, Pastor CM, Hussain HK, Primovist, Eovist: what to expect?, in J. Hepatol., vol. 57, n. 2, agosto 2012, pp. 421-9, DOI:10.1016/j.jhep.2012.01.031, PMID 22504332.
(EN) Cho SH, Kang UR, Kim JD, Han YS, Choi DL, The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study, in Eur J Radiol, vol. 80, n. 2, novembre 2011, pp. e195–200, DOI:10.1016/j.ejrad.2011.08.008, PMID 21908121.
(EN) Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, Doi K, Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging, in Radiology, vol. 260, n. 3, settembre 2011, pp. 727-33, DOI:10.1148/radiol.11100586, PMID 21712472.
(EN) Mathew RP, Venkatesh SK, Imaging of Hepatic Fibrosis, in Curr Gastroenterol Rep, vol. 20, n. 10, agosto 2018, p. 45, DOI:10.1007/s11894-018-0652-7, PMID 30159792.
(EN) Keller S, Sedlacik J, Schuler T, Buchert R, Avanesov M, Zenouzi R, Lohse AW, Kooijman H, Fiehler J, Schramm C, Yamamura J, Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis, in Eur Radiol, luglio 2018, DOI:10.1007/s00330-018-5614-9, PMID 30014204.
(EN) Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G, Sirlin CB, MR imaging of liver fibrosis: current state of the art, in Radiographics, vol. 29, n. 6, ottobre 2009, pp. 1615-35, DOI:10.1148/rg.296095512, PMID 19959511.
(EN) Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM, Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence, in Radiology, vol. 181, n. 3, dicembre 1991, pp. 805-8, DOI:10.1148/radiology.181.3.1947101, PMID 1947101. URL consultato il 12 marzo 2018.
(EN) Venkatesh SK, Talwalkar JA, When and how to use magnetic resonance elastography for patients with liver disease in clinical practice, in Am. J. Gastroenterol., vol. 113, n. 7, luglio 2018, pp. 923-926, DOI:10.1038/s41395-018-0012-0, PMID 29487410.
(EN) Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL, Magnetic resonance elastography: non-invasive mapping of tissue elasticity, in Med Image Anal, vol. 5, n. 4, dicembre 2001, pp. 237-54, PMID 11731304.
(EN) Sheth SG, Amarapurkar DN, Chopra KB, Mehta PJ, Significance of radioisotope bone marrow uptake on 99m technetium sulphocolloid scan in portal hypertension, in J Assoc Physicians India, vol. 44, n. 5, maggio 1996, pp. 310-2, PMID 9282577.
(EN) Chakraborty D, Sunil HV, Mittal BR, Bhattacharya A, Singh B, Chawla Y, Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver, in Indian J Nucl Med, vol. 25, n. 4, ottobre 2010, pp. 139-42, DOI:10.4103/0972-3919.78247, PMC 3109819, PMID 21713221.
(EN) Lockwood AH, Positron emission tomography in the study of hepatic encephalopathy, in Metab Brain Dis, vol. 17, n. 4, dicembre 2002, pp. 431-5, PMID 12602518.
(EN) Krystallis C, Masterton GS, Hayes PC, Plevris JN, Update of endoscopy in liver disease: more than just treating varices, in World J. Gastroenterol., vol. 18, n. 5, febbraio 2012, pp. 401-11, DOI:10.3748/wjg.v18.i5.401, PMC 3272639, PMID 22346246.
(EN) Simon K, Orłowska I, Pazgan-Simon M, The risk of complications of endoscopic procedures in patients with liver cirrhosis, in Clin Exp Hepatol, vol. 3, n. 3, settembre 2017, pp. 135-140, DOI:10.5114/ceh.2017.70284, PMC 5649487, PMID 29062903.
(EN) Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R, Transection of the oesophagus for bleeding oesophageal varices, in Br J Surg, vol. 60, n. 8, 1973, pp. 646-9, DOI:10.1002/bjs.1800600817, PMID 4541913.
(EN) M. Malinchoc, PS. Kamath; FD. Gordon; CJ. Peine; J. Rank; PC. ter Borg, A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts., in Hepatology, vol. 31, n. 4, aprile 2000, pp. 864-71, DOI:10.1053/he.2000.5852, PMID 10733541.
(EN) PS. Kamath, WR. Kim, The model for end-stage liver disease (MELD)., in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) Patch D, Armonis A, Sabin C, et al., Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding, in Gut, vol. 44, n. 2, 1999, pp. 264-9, DOI:10.1136/gut.44.2.264, PMC 1727391, PMID 9895388.
(EN) Chandok N, Watt KD, Pain management in the cirrhotic patient: the clinical challenge, in Mayo Clin. Proc., vol. 85, n. 5, maggio 2010, pp. 451-8, DOI:10.4065/mcp.2009.0534, PMC 2861975, PMID 20357277.
(EN) Hong YM, Yoon KT, Heo J, Woo HY, Lim W, An DS, Han JH, Cho M, The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis, in J. Korean Med. Sci., vol. 31, n. 10, ottobre 2016, pp. 1604-10, DOI:10.3346/jkms.2016.31.10.1604, PMC 4999403, PMID 27550489.
(EN) Toshikuni N, Arisawa T, Tsutsumi M, Nutrition and exercise in the management of liver cirrhosis, in World J. Gastroenterol., vol. 20, n. 23, giugno 2014, pp. 7286-97, DOI:10.3748/wjg.v20.i23.7286, PMC 4064074, PMID 24966599.
(EN) Nusrat S, Khan MS, Fazili J, Madhoun MF, Cirrhosis and its complications: evidence based treatment, in World J. Gastroenterol., vol. 20, n. 18, maggio 2014, pp. 5442-60, DOI:10.3748/wjg.v20.i18.5442, PMC 4017060, PMID 24833875.
(EN) Perri GA, Khosravani H, Complications of end-stage liver disease, in Can Fam Physician, vol. 62, n. 1, gennaio 2016, pp. 44-50, PMC 4721840, PMID 26796834.
(EN) NC Chavez-Tapia, T Barrientos-Gutierrez, FI Tellez-Avila, K Soares-Weiser e M Uribe, Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding., in The Cochrane Database of Systematic Reviews, n. 9, 8 settembre 2010, pp. CD002907, DOI:10.1002/14651858.CD002907.pub2, PMID 20824832.
(EN) Moctezuma-Velazquez C, Kalainy S, Abraldes JG, Beta-blockers in patients with advanced liver disease: Has the dust settled?, in Liver Transpl., vol. 23, n. 8, agosto 2017, pp. 1058-1069, DOI:10.1002/lt.24794, PMID 28590564.
(EN) Kamath PS, Kim WR, The model for end-stage liver disease (MELD), in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P, Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals, in J. Hepatol., settembre 2018, DOI:10.1016/j.jhep.2018.08.028, PMID 30243996.
(EN) Kimbell B, Murray SA, What is the patient experience in advanced liver disease? A scoping review of the literature, in BMJ Support Palliat Care, vol. 5, n. 5, dicembre 2015, pp. 471-80, DOI:10.1136/bmjspcare-2012-000435, PMID 24644180.
(EN) Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ, Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation, in J Pain Symptom Manage, vol. 50, n. 6, dicembre 2015, pp. 882–6.e2, DOI:10.1016/j.jpainsymman.2015.07.014, PMID 26303186.
(EN) W Sanchez e JA Talwalkar, Palliative care for patients with end-stage liver disease ineligible for liver transplantation., in Gastroenterology clinics of North America, vol. 35, n. 1, marzo 2006, pp. 201-19, DOI:10.1016/j.gtc.2005.12.007, PMID 16530121.
(EN) Z Poonja, A Brisebois, SV van Zanten, P Tandon, G Meeberg e CJ Karvellas, Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management., in Clinical Gastroenterology and Hepatology, vol. 12, n. 4, aprile 2014, pp. 692-8, DOI:10.1016/j.cgh.2013.08.027, PMID 23978345.
(EN) E Cholongitas, Papatheodoridis, GV, Vangeli, M, Terreni, N, Patch, D e Burroughs, AK, Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, in Alimentary Pharmacology & Therapeutics, vol. 22, n. 11-12, dicembre 2005, pp. 1079-89, DOI:10.1111/j.1365-2036.2005.02691.x/full, PMID 16305721.
(EN) RN. Pugh, IM. Murray-Lyon; JL. Dawson; MC. Pietroni; R. Williams, Transection of the oesophagus for bleeding oesophageal varices., in Br J Surg, vol. 60, n. 8, agosto 1973, pp. 646-9, PMID 4541913.

niddk.nih.gov

(EN) Cirrhosis, su National Institute of Diabetes and Digestive and Kidney Diseases, 23 aprile 2014. URL consultato il 19 maggio 2015 (archiviato il 9 giugno 2015).

oadoi.org

(EN) Klatsky AL, Morton C, Udaltsova N, Friedman GD, Coffee, cirrhosis, and transaminase enzymes, in Archives of Internal Medicine, vol. 166, n. 11, 2006, pp. 1190-5, DOI:10.1001/archinte.166.11.1190, PMID 16772246.
(EN) CQ Edwards e Kushner, JP, Screening for hemochromatosis., in The New England Journal of Medicine, vol. 328, n. 22, 3 giugno 1993, pp. 1616-20, DOI:10.1056/NEJM199306033282208, PMID 8110209.
(EN) Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397-408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
(EN) Giallourakis CC, Rosenberg PM, Friedman LS, The liver in heart failure, in Clin Liver Dis, vol. 6, n. 4, novembre 2002, pp. 947–67, viii–ix, DOI:10.1016/S1089-3261(02)00056-9, PMID 12516201.
(EN) Heathcote EJ, Primary biliary cirrhosis: historical perspective, in Clin Liver Dis, vol. 7, n. 4, novembre 2003, pp. 735-40, DOI:10.1016/S1089-3261(03)00098-9, PMID 14594128.
(EN) Sundaram V, Shaikh OS, Hepatic encephalopathy: pathophysiology and emerging therapies, in Med. Clin. North Am., vol. 93, n. 4, luglio 2009, pp. 819–36, vii, DOI:10.1016/j.mcna.2009.03.009, PMID 19577116.
(EN) Riordan SM, Williams R, The intestinal flora and bacterial infection in cirrhosis, in J. Hepatol., vol. 45, n. 5, novembre 2006, pp. 744-57, DOI:10.1016/j.jhep.2006.08.001, PMID 16979776.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E, Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: the Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) Adinolfi LE, Nevola R, Rinaldi L, Romano C, Giordano M, Chronic Hepatitis C Virus Infection and Depression, in Clin Liver Dis, vol. 21, n. 3, agosto 2017, pp. 517-534, DOI:10.1016/j.cld.2017.03.007, PMID 28689590.
(EN) JA Udell, Wang, CS, Tinmouth, J, FitzGerald, JM, Ayas, NT, Simel, DL, Schulzer, M, Mak, E e Yoshida, EM, Does this patient with liver disease have cirrhosis?, in JAMA: The Journal of the American Medical Association, vol. 307, n. 8, 22 febbraio 2012, pp. 832-42, DOI:10.1001/jama.2012.186, PMID 22357834.
(EN) Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski e Lech Chrostek, Selected Noninvasive Markers in Diagnosing Liver Diseases, in Laboratory Medicine, vol. 47, n. 1, 2016, pp. 67-72, DOI:10.1093/labmed/lmv015, ISSN 0007-5027 (WC · ACNP).
(EN) Halfon P, Munteanu M, Poynard T, FibroTest-ActiTest as a non-invasive marker of liver ﬁbrosis, in Gastroenterol Clin Biol, vol. 32, n. 6, settembre 2008, pp. 22-39, DOI:10.1016/S0399-8320(08)73991-5, PMID 18973844.
(EN) Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V, Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C, in Gastroenterology, vol. 140, n. 7, giugno 2011, pp. 1970–9, 1979.e1–3, DOI:10.1053/j.gastro.2011.02.058, PMID 21376047.
(EN) Van Beers BE, Pastor CM, Hussain HK, Primovist, Eovist: what to expect?, in J. Hepatol., vol. 57, n. 2, agosto 2012, pp. 421-9, DOI:10.1016/j.jhep.2012.01.031, PMID 22504332.
(EN) Cho SH, Kang UR, Kim JD, Han YS, Choi DL, The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study, in Eur J Radiol, vol. 80, n. 2, novembre 2011, pp. e195–200, DOI:10.1016/j.ejrad.2011.08.008, PMID 21908121.
(EN) NC Chavez-Tapia, T Barrientos-Gutierrez, FI Tellez-Avila, K Soares-Weiser e M Uribe, Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding., in The Cochrane Database of Systematic Reviews, n. 9, 8 settembre 2010, pp. CD002907, DOI:10.1002/14651858.CD002907.pub2, PMID 20824832.
(EN) Kamath PS, Kim WR, The model for end-stage liver disease (MELD), in Hepatology, vol. 45, n. 3, marzo 2007, pp. 797-805, DOI:10.1002/hep.21563, PMID 17326206.
(EN) Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P, Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals, in J. Hepatol., settembre 2018, DOI:10.1016/j.jhep.2018.08.028, PMID 30243996.
(EN) Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ, Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation, in J Pain Symptom Manage, vol. 50, n. 6, dicembre 2015, pp. 882–6.e2, DOI:10.1016/j.jpainsymman.2015.07.014, PMID 26303186.
(EN) W Sanchez e JA Talwalkar, Palliative care for patients with end-stage liver disease ineligible for liver transplantation., in Gastroenterology clinics of North America, vol. 35, n. 1, marzo 2006, pp. 201-19, DOI:10.1016/j.gtc.2005.12.007, PMID 16530121.
(EN) Z Poonja, A Brisebois, SV van Zanten, P Tandon, G Meeberg e CJ Karvellas, Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management., in Clinical Gastroenterology and Hepatology, vol. 12, n. 4, aprile 2014, pp. 692-8, DOI:10.1016/j.cgh.2013.08.027, PMID 23978345.
(EN) E Cholongitas, Papatheodoridis, GV, Vangeli, M, Terreni, N, Patch, D e Burroughs, AK, Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, in Alimentary Pharmacology & Therapeutics, vol. 22, n. 11-12, dicembre 2005, pp. 1079-89, DOI:10.1111/j.1365-2036.2005.02691.x/full, PMID 16305721.

oecd-ilibrary.org

(EN) OECD/EU (2016), Health at a Glance: Europe 2016, Health at a Glance: Europe 2016, Paris, 2016, ISBN 978-92-64-26559-2.

oup.com

academic.oup.com

(EN) von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M, Portal vein thrombosis in patients with cirrhosis, in Gastroenterol Rep (Oxf), vol. 5, n. 2, maggio 2017, pp. 148-156, DOI:10.1093/gastro/gox014, PMC 5421355, PMID 28533912.

ovid.com

Insights.ovid.com

(EN) Al-Jameil N, Hassan AA, Buhairan A, Hassanato R, Isac SR, Al-Otaiby M, Al-Maarik B, Al-Ajeyan I, Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis, in Medicine (Baltimore), vol. 96, n. 6, febbraio 2017, pp. e6071, DOI:10.1097/MD.0000000000006071, PMC 5313019, PMID 28178162.

quintessenz.de

qi.quintessenz.de

(EN) Jaiswal G, Deo V, Bhongade M, Jaiswal S, Serum alkaline phosphatase: a potential marker in the progression of periodontal disease in cirrhosis patients, in Quintessence Int, vol. 42, n. 4, aprile 2011, pp. 345-8, PMID 21516281.

rsna.org

pubs.rsna.org

(EN) Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, Doi K, Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging, in Radiology, vol. 260, n. 3, settembre 2011, pp. 727-33, DOI:10.1148/radiol.11100586, PMID 21712472.
(EN) Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G, Sirlin CB, MR imaging of liver fibrosis: current state of the art, in Radiographics, vol. 29, n. 6, ottobre 2009, pp. 1615-35, DOI:10.1148/rg.296095512, PMID 19959511.
(EN) Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM, Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence, in Radiology, vol. 181, n. 3, dicembre 1991, pp. 805-8, DOI:10.1148/radiology.181.3.1947101, PMID 1947101. URL consultato il 12 marzo 2018.

salute.gov.it

Ministero della salute, Guida utile all'identificazione e alla diagnosi dei problemi alcol-relati (PDF), su salute.gov.it. URL consultato il 28 luglio 2019.

scielo.br

(EN) Meirelles Júnior RF, Salvalaggio P, Rezende MB, Evangelista AS, Guardia BD, Matielo CE, Neves DB, Pandullo FL, Felga GE, Alves JA, Curvelo LA, Diaz LG, Rusi MB, Viveiros Mde M, Almeida MD, Pedroso PT, Rocco RA, Meira Filho SP, Liver transplantation: history, outcomes and perspectives, in Einstein (Sao Paulo), vol. 13, n. 1, 2015, pp. 149-52, DOI:10.1590/S1679-45082015RW3164, PMC 4977591, PMID 25993082.

thelancet.com

(EN) C.J. Murray, Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 (abstract), in Lancet, vol. 380, 2012, pp. 2197-2223, PMID 23245608.

thieme-connect.com

(EN) Nolte W, Hartmann H, Ramadori G, Glucose metabolism and liver cirrhosis, in Exp. Clin. Endocrinol. Diabetes, vol. 103, n. 2, 1995, pp. 63-74, DOI:10.1055/s-0029-1211331, PMID 7553077.

treccani.it

Cirrosi, in Treccani.it – Enciclopedie on line, Roma, Istituto dell'Enciclopedia Italiana.

unibo.it

acnpsearch.unibo.it

(EN) Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski e Lech Chrostek, Selected Noninvasive Markers in Diagnosing Liver Diseases, in Laboratory Medicine, vol. 47, n. 1, 2016, pp. 67-72, DOI:10.1093/labmed/lmv015, ISSN 0007-5027 (WC · ACNP).

uw.edu

hepatitisc.uw.edu

(EN) Karla Thornton, Evaluation and Prognosis of Patients with Cirrhosis, su hepatitisc.uw.edu. URL consultato il 2 novembre 2018.
(EN) Hepatits C Online, Evaluation and Prognosis of Patients with Cirrhosis, su hepatitisc.uw.edu. URL consultato il 2 novembre 2018.

web.archive.org

(EN) Cirrhosis, su National Institute of Diabetes and Digestive and Kidney Diseases, 23 aprile 2014. URL consultato il 19 maggio 2015 (archiviato il 9 giugno 2015).
(EN) Steven T. Brower, Elective general surgery : an evidence-based approach, New York, McGraw-Hill Medical, 2012, p. 36, ISBN 978-1-60795-109-4 (archiviato l'8 settembre 2017).
Servizio Sanitario Regionale dell'Emilia Romagna, Cirrosi epatica, su asmn.re.it. URL consultato il 2 novembre 2018 (archiviato dall'url originale il 26 novembre 2018).
(EN) European Association, EASL Clinical Practice Guidelines: Wilson’s disease (PDF), in J. Hepatol., vol. 56, 2012, pp. 671-685, PMID 22340672. URL consultato il 25 novembre 2018 (archiviato dall'url originale il 23 novembre 2018).
(EN) MELD/PELD Calculator Documentation (PDF), su unos.org, 28 gennaio 2009, pp. 1-4. URL consultato il 23 ottobre 2018 (archiviato dall'url originale il 9 febbraio 2020).
(EN) E-medicine liver transplant outlook and survival rates, su emedicinehealth.com, 9 giugno 2009. URL consultato il 6 settembre 2009 (archiviato il 14 luglio 2009).

who.int

(EN) WHO Disease and injury country estimates, su World Health Organization, 2009. URL consultato l'11 novembre 2009.
World Health Organization, Global status report on alcohol and health (PDF), su who.int. URL consultato il 28 luglio 2019.

wiley.com

onlinelibrary.wiley.com

(EN) A. Siddique, Review article: the iron overload syndromes, in Aliment. Pharmacol. Ther., vol. 35, 2012, pp. 876-893, PMID 22385471.
(EN) M. Franchini, Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment, in Am. J. Hematol., vol. 81, 2006, pp. 202-209, PMID 16493621.

wjgnet.com

(EN) Giunta M, Conte D, Fraquelli M, Role of spleen elastography in patients with chronic liver diseases, in World J. Gastroenterol., vol. 22, n. 35, settembre 2016, pp. 7857-67, DOI:10.3748/wjg.v22.i35.7857, PMC 5028802, PMID 27672283.
(EN) Krystallis C, Masterton GS, Hayes PC, Plevris JN, Update of endoscopy in liver disease: more than just treating varices, in World J. Gastroenterol., vol. 18, n. 5, febbraio 2012, pp. 401-11, DOI:10.3748/wjg.v18.i5.401, PMC 3272639, PMID 22346246.
(EN) Toshikuni N, Arisawa T, Tsutsumi M, Nutrition and exercise in the management of liver cirrhosis, in World J. Gastroenterol., vol. 20, n. 23, giugno 2014, pp. 7286-97, DOI:10.3748/wjg.v20.i23.7286, PMC 4064074, PMID 24966599.
(EN) Nusrat S, Khan MS, Fazili J, Madhoun MF, Cirrhosis and its complications: evidence based treatment, in World J. Gastroenterol., vol. 20, n. 18, maggio 2014, pp. 5442-60, DOI:10.3748/wjg.v20.i18.5442, PMC 4017060, PMID 24833875.

worldcat.org

(EN) Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski e Lech Chrostek, Selected Noninvasive Markers in Diagnosing Liver Diseases, in Laboratory Medicine, vol. 47, n. 1, 2016, pp. 67-72, DOI:10.1093/labmed/lmv015, ISSN 0007-5027 (WC · ACNP).